We are live on ! Find out more
VCYT icon

Veracyte

214 hedge funds and large institutions have $3.46B invested in Veracyte in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 72 increasing their positions, 76 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more capital invested

Capital invested by funds: $2.89B → $3.46B (+$569M)

3% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 29

0% more funds holding

Funds holding: 214214 (0)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

5% less repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 76

2.2% less ownership

Funds ownership: 108.2%106% (-2.2%)

29% less call options, than puts

Call options by funds: $617K | Put options by funds: $870K

Holders
214
Holders Change
Holders Change %
0%
% of All Funds
3.75%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
30
Increased
72
Reduced
76
Closed
29
Calls
$617K
Puts
$870K
Net Calls
-$253K
Net Calls Change
+$283K
Name Holding Trade Value Shares
Change
Change in
Stake
PPA
76
Parametric Portfolio Associates
Washington
$3.22M -$166K -3,815 -5%
CS
77
Credit Suisse
Switzerland
$3.2M +$221K +5,072 +8%
Rafferty Asset Management
78
Rafferty Asset Management
New York
$2.97M -$355K -8,143 -11%
Victory Capital Management
79
Victory Capital Management
Texas
$2.95M -$153K -3,508 -5%
Skandinaviska Enskilda Banken (SEB)
80
Skandinaviska Enskilda Banken (SEB)
Sweden
$2.77M +$1.52M +34,846 +141%
Susquehanna International Group
81
Susquehanna International Group
Pennsylvania
$2.56M +$298K +6,839 +14%
PFM
82
Premier Fund Managers
United Kingdom
$2.56M
Prudential Financial
83
Prudential Financial
New Jersey
$2.48M +$304K +6,967 +15%
FG
84
Formula Growth
Quebec, Canada
$2.42M
HM
85
HealthCor Management
New York
$2.31M +$2.17M +49,640 New
PHP
86
Parkman Healthcare Partners
Connecticut
$2.09M +$1.96M +45,000 New
Russell Investments Group
87
Russell Investments Group
United Kingdom
$2.03M +$574K +13,165 +43%
JP Morgan Chase
88
JP Morgan Chase
New York
$2.03M -$670K -15,359 -26%
Envestnet Asset Management
89
Envestnet Asset Management
Illinois
$1.86M +$74.8K +1,713 +4%
BC
90
Brookfield Corp
Ontario, Canada
$1.78M +$720K +16,496 +76%
Dimensional Fund Advisors
91
Dimensional Fund Advisors
Texas
$1.78M -$1.19M -27,257 -42%
AAM
92
Advisors Asset Management
Colorado
$1.75M -$246K -5,632 -13%
Ameriprise
93
Ameriprise
Minnesota
$1.74M -$438K -10,041 -21%
AIG
94
American International Group
New York
$1.72M -$38.3K -877 -2%
Manulife (Manufacturers Life Insurance)
95
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.59M -$150K -3,446 -9%
CSS
96
Cubist Systematic Strategies
Connecticut
$1.58M -$2.67M -61,228 -64%
GC
97
Guggenheim Capital
Illinois
$1.58M -$193K -4,418 -11%
AIM
98
Artemis Investment Management
United Kingdom
$1.49M +$341K +7,811 +32%
T. Rowe Price Associates
99
T. Rowe Price Associates
Maryland
$1.48M +$55K +1,261 +4%
GAM
100
Gotham Asset Management
New York
$1.41M +$1.32M +30,299 New

VCYT Hedge Fund Activity: Q3 2021 in Review

214 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q3 2021, worth a combined $3.46B — up 20% from $2.89B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new VCYT positions and 29 closed out — a net gain of 1 holder — while 72 added to existing stakes and 76 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $101M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $70.9M.

  • 214 institutional investors held Veracyte (VCYT) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $3.46B of Veracyte stock for Q3 2021, up 20% quarter-over-quarter.
  • 30 funds opened new Veracyte positions in Q3 2021 and 29 closed out, a net change of +1 holder.
  • The largest Veracyte buyer in Q3 2021 was Wellington Management Group, an estimated $101M added.
  • The largest Veracyte seller in Q3 2021 was Gilder Gagnon Howe & Co, an estimated $70.9M sold.

Based on aggregated 13F filings for Q3 2021.